Oleylethanolamide: A lipid mediator involved in gut satiety mechanisms [4]

Journal of Gastroenterology and Hepatology (Australia)

Volumn 19, Issue 1, 2004, Pages 117-

  Inui, Akio ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANANDAMIDE; CANNABINOID; CHOLECYSTOKININ OCTAPEPTIDE; ETHANOLAMINE DERIVATIVE; NEUROHORMONE; OLEYLETHANOLAMIDE; UNCLASSIFIED DRUG;

ANOREXIA; BRAIN DEPTH STIMULATION; CACHEXIA; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; FEEDING; FOOD INTAKE; HOMEOSTASIS; HORMONAL REGULATION; HORMONE SYNTHESIS; HYPOTHALAMUS; INTESTINE FUNCTION; LETTER; OBESITY; PRIORITY JOURNAL; SATIETY; SENSORY NERVE; THALAMUS MIDLINE NUCLEUS; TREATMENT INDICATION; VAGUS NERVE STIMULATION; WEIGHT GAIN;

EID: 1642480101     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2004.03197.x     Document Type: Letter

References (5)

1. Inui A. Transgenic approach to the study of body weight regulation. Pharmacol. Rev. 2000; 52: 35-61.
2. Inui A. Transgenic study of energy homeostasis equation: Implications and confounding influences. FASEB J. 2000; 14: 2158-70.
3. Schwartz MW, Woods SC, Porte D Jr et al. Central nervous system control of food intake. Nature 2000; 404: 661-71.
4. De Fonseca FR, Navarro M, Gomez R et al. An anorexigenic lipid mediator regulated by feeding. Nature 2001; 414: 209-12.
5. Inui A. Cancer anorexia-cachexia syndrome. Current issues in research and management. CA Cancer J. Clin. 2002; 52: 72-91.